(Q34792269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

2

Bridget Zimmerman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1

Sohan Singh Hayreh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

355-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12190776%20AND%20SRC:MED&resulttype=core&format=json

Cortisone therapy of visual loss in temporal arteritis

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Treatable blindness in temporal arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Anterior ischaemic optic neuropathy. II. Fundus on ophthalmoscopy and fluorescein angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

The 1994 Von Sallman Lecture. The optic nerve head circulation in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

The blood supply of the optic nerve head and the evaluation of it - myth and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Giant cell arteritis: validity and reliability of various diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Occult giant cell arteritis: ocular manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Ischemic papilledema in giant-cell arteritis. Mucopolysaccharide deposition with normal intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Pathologic findings in a steroid-responsive optic nerve infarct in giant-cell arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Gradual loss and recovery of vision in temporal arteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Ciliary artery involvement in giant cell arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Fundus signs in temporal arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Reversal of blindness in temporal arteritis with methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Sudden blindness in cranial arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Laser Doppler flowmetry and optic nerve head blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

21 January 2018

2 references

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

21 January 2018

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Visual prognosis in giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Temporal arteritis syndrome; a case report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

IV steroids for central retinal artery occlusion in giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Recovery of visual function in anterior ischemic optic neuropathy due to giant cell arteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

OCCULT TEMPORAL ARTERITIS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Prognosis in giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

THE OPHTHALMIC ARTERY: III. BRANCHES.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Retinal arterial occlusion with LIF using rTPA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Steroid therapy for visual loss in patients with giant-cell arteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Occlusion of the posterior ciliary artery. V. Protective influence of simultaneous vortex vein occlusion.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: an experimental study in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Ocular manifestations of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Histopathology of ischemic optic neuropathy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Visual Recovery in Two Patients after Intravenous Methylprednisolone Treatment of Central Retinal Artery Occlusion Secondary to Giant-cell Arteries

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Treatment of temporal arteritis with ocular involvement

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Atypical visual loss in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021

Temporal arteritis and its treatment with cortisone and A.C.T.H.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800403.X

7 January 2021